InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.020
-0.030 (-2.86%)
At close: Jun 5, 2026, 4:00 PM EDT
0.9703
-0.0500 (-4.87%)
After-hours: Jun 5, 2026, 6:50 PM EDT
InterCure Market Cap
InterCure has a market cap or net worth of $55.69 million as of June 5, 2026. Its market cap has decreased by -28.36% in one year.
Market Cap
55.69M
Enterprise Value
102.01M
1-Year Change
-28.36%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $55.69M, an increase of 3,026.42%. That is a compound annual growth rate of 24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 55.69M | 0.33% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 86.90M |
| Citius Oncology | 68.85M |
| BGM Group | 53.53M |
| SCYNEXIS | 46.77M |
| Talphera | 40.22M |
| Zhengye Biotechnology Holding | 39.36M |
| Incannex Healthcare | 34.94M |
| BioXcel Therapeutics | 34.12M |